Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Diabetes / Metabolic Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

2236 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

2236 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Oncology
Lung cAncer Robotic Comparative Study
Lung cAncer Robotic Comparative Study is Recruiting • Phase not applicable • Oncology • NCT06038227. To compare outcomes of minimally invasive surgical techniques for…
06 Apr 2026 NCT06038227
● Recruiting Respiratory / COPD / Asthma
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung – Study 3
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung – Study 3 is Recruiting • Phase not applicable • Respiratory / COPD / Asthma…
06 Apr 2026 NCT06891755
● Recruiting Cardiology / Cardiovascular
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure is Recruiting • Phase not applicable • Cardiology / Cardiovascular •…
06 Apr 2026 NCT06557798
● Recruiting Phase II Cardiology / Cardiovascular
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes is Recruiting • Phase II • Cardiology / Cardiovascular • NCT06435156. People with…
06 Apr 2026 NCT06435156
● Recruiting Phase II Oncology
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) is Recruiting • Phase II • Oncology • NCT06833073.…
06 Apr 2026 NCT06833073
● Recruiting Phase I Oncology
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer is Recruiting • Phase I • Oncology • NCT04360941. This clinical study is…
06 Apr 2026 NCT04360941
● Recruiting Phase I Oncology
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors is Recruiting • Phase…
06 Apr 2026 NCT04774718
● Recruiting Oncology
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test is Recruiting • Phase not applicable • Oncology • NCT04529122. WAYFIND-R is…
06 Apr 2026 NCT04529122
● Recruiting Phase II Oncology
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis is Recruiting • Phase II • Oncology…
06 Apr 2026 NCT04910685
● Recruiting Phase I Oncology
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia is Recruiting • Phase I • Oncology •…
06 Apr 2026 NCT07109219
● Recruiting Phase II Oncology
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)…
03 Apr 2026 NCT06534983
● Recruiting Phase III
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps…
03 Apr 2026 NCT06834347
active not recruiting Phase III Rare Diseases
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia…
03 Apr 2026 NCT03861273
● Recruiting Phase II
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab is Recruiting…
03 Apr 2026 NCT07039422
active not recruiting Phase I / Phase II Oncology
A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.
A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. is Active Not…
03 Apr 2026 NCT06116136
active not recruiting Phase I
A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234 is Active Not Recruiting • Phase I • NCT07220954. Review the linked…
03 Apr 2026 NCT07220954
● Recruiting Phase III
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation is Recruiting •…
03 Apr 2026 NCT06465953
● Recruiting Phase III Oncology
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents is Recruiting • Phase III • Oncology…
03 Apr 2026 NCT06120491
● Recruiting Phase III Oncology
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. is Recruiting • Phase III • Oncology • NCT06382948.…
03 Apr 2026 NCT06382948
● Recruiting Phase III Respiratory / COPD / Asthma
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease is Recruiting • Phase III • Respiratory / COPD / Asthma • NCT07169578.…
03 Apr 2026 NCT07169578
● Recruiting Phase I Neurology
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer’s Disease (eAD)
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer’s Disease (eAD) is Recruiting • Phase…
03 Apr 2026 NCT07234942
● Recruiting Phase III Gastroenterology
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH is Recruiting • Phase III •…
03 Apr 2026 NCT06419374
● Recruiting Phase I Oncology
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer is Recruiting…
03 Apr 2026 NCT06764316
● Recruiting Phase II Rheumatology
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety…
03 Apr 2026 NCT05039619
● Recruiting Phase II Mental Health / Psychiatry
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease is Recruiting • Phase II •…
03 Apr 2026 NCT07355296
● Recruiting Infectious Disease
Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission
Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission is Recruiting • Phase not applicable • Infectious…
03 Apr 2026 NCT07300254
● Recruiting Phase II Rheumatology
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) is Recruiting…
03 Apr 2026 NCT06979336
● Recruiting Phase III Respiratory / COPD / Asthma
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) is Recruiting • Phase III • Respiratory / COPD / Asthma…
03 Apr 2026 NCT05722938
● Recruiting Phase III Oncology
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of…
03 Apr 2026 NCT06646276
● Recruiting Phase III Oncology
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand…
03 Apr 2026 NCT06345729
● Recruiting Phase I Oncology
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements is Recruiting • Phase I • Oncology…
03 Apr 2026 NCT03093116
● Recruiting Phase III Respiratory / COPD / Asthma
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) is Recruiting •…
03 Apr 2026 NCT06667700
● Recruiting Phase II Cardiology / Cardiovascular
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney…
03 Apr 2026 NCT07222917
● Recruiting Cardiology / Cardiovascular
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area – Post-Market Clinical Follow-up
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area – Post-Market Clinical Follow-up is Recruiting • Phase not applicable • Cardiology…
03 Apr 2026 NCT07209852
● Recruiting Cardiology / Cardiovascular
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease is Recruiting • Phase not applicable •…
03 Apr 2026 NCT06259019
● Recruiting Phase III Cardiology / Cardiovascular
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin is Recruiting • Phase III • Cardiology / Cardiovascular…
03 Apr 2026 NCT06677060
● Recruiting Phase III Oncology
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive…
03 Apr 2026 NCT06790693
● Recruiting Phase III Oncology
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. is Recruiting • Phase III • Oncology…
03 Apr 2026 NCT05727904
● Recruiting Phase II Oncology
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) is Recruiting •…
03 Apr 2026 NCT04256317
● Recruiting Phase II Oncology
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or…
03 Apr 2026 NCT07137598
● Recruiting Phase II Oncology
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) is Recruiting • Phase II • Oncology • NCT04728893. The purpose of…
03 Apr 2026 NCT04728893
● Recruiting Phase I Oncology
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally…
03 Apr 2026 NCT06031441
● Recruiting Phase II Oncology
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) is Recruiting • Phase II • Oncology • NCT07209111. Researchers want…
03 Apr 2026 NCT07209111
● Recruiting Oncology
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN) is Recruiting • Phase not applicable • Oncology •…
03 Apr 2026 NCT06408441
active not recruiting Phase III Dermatology
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura is Active Not Recruiting • Phase III • Dermatology • NCT04683003. Review the…
02 Apr 2026 NCT04683003
● Recruiting Phase III Diabetes / Metabolic
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight is Recruiting • Phase III •…
02 Apr 2026 NCT07253285
● Recruiting Oncology
Cutaneous Squamous Cell Carcinoma Staging Study
Cutaneous Squamous Cell Carcinoma Staging Study is Recruiting • Phase not applicable • Oncology • NCT05695222. Review the linked registry entry for study design,…
02 Apr 2026 NCT05695222
● Recruiting Phase III Rheumatology
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) is Recruiting • Phase III • Rheumatology • NCT07116967. Review the linked…
02 Apr 2026 NCT07116967
active not recruiting Dermatology
Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology
Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology is Active Not Recruiting • Phase not applicable • Dermatology •…
02 Apr 2026 NCT06327971
active not recruiting Phase II Respiratory / COPD / Asthma
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) is Active Not Recruiting • Phase II •…
02 Apr 2026 NCT06966479